|
Molecular Targets
Development Program |
|
Collaborative Research Opportunities
|
|
|
The primary focus of MTDP is the
collaborative creation, adaptation and use of state-of-the-art biomolecular
screening technologies to discover compounds (including non-peptidic, peptidic
and proteinaceous compounds) that selectively interact with or modify functions
of specific molecular targets (e.g., endogenous molecules, structures,
processes or pathways) of priority interest to the CCR, NCI. Tangible products
of these efforts include novel or known compounds that may be used as
"bioprobes" for target validation research or as drug discovery leads or
templates. Accordingly, collaborative research opportunities include the
following:
|
|
© 2000-2005 Center for Cancer Research
at the National Cancer Institute. questions, comments, and suggestions to
webmaster Last modified November 14,
2005 |
|
Home |
Mission | Organization |
News |
|